PubRank

Anne Griffiths

Author PubWeight™ 74.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006 27.49
2 Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009 3.82
3 Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2010 3.55
4 Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2006 3.32
5 Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 2009 3.19
6 Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005 1.98
7 Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet 2010 1.81
8 Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease. Transplantation 2004 1.45
9 Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2002 1.43
10 Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 2008 1.42
11 Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 2007 1.37
12 Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol 2006 1.33
13 The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006 1.33
14 Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis 2007 1.26
15 Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis 2007 1.17
16 Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 2008 1.17
17 Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr 2009 1.15
18 Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol 2010 1.14
19 Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis 2009 1.13
20 Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 2007 1.10
21 Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. Gastroenterology 2012 1.07
22 Severe ulcerative colitis after rituximab therapy. Pediatrics 2010 1.03
23 CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features. Am J Med Genet A 2005 1.00
24 Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. Clin Gastroenterol Hepatol 2011 1.00
25 Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 2007 0.99
26 Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis 2009 0.97
27 Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD. Respirology 2009 0.91
28 Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol 2011 0.87
29 Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease. J Crohns Colitis 2012 0.86
30 Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transplant 2008 0.86
31 Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease. Can J Gastroenterol 2004 0.85
32 Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J Pediatr Gastroenterol Nutr 2013 0.85
33 Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH. J Pediatr Gastroenterol Nutr 2009 0.81
34 Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 study. Inflamm Bowel Dis 2013 0.81
35 Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension. Curr Med Res Opin 2011 0.80
36 Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2015 0.80
37 Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease. Inflamm Bowel Dis 2015 0.78
38 O-009 Long ncRNA Landscape in the Ileum of Treatment Naïve Early Onset Crohn Disease. Inflamm Bowel Dis 2017 0.75
39 The Alfred Hospital lung transplant experience. Clin Transpl 2007 0.75
40 Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit. Inflamm Bowel Dis 2017 0.75
41 Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis. Am J Surg Pathol 2017 0.75
42 Corticosteroid Dosing in Pediatric Acute Severe Ulcerative Colitis: A Propensity Score Analysis. J Pediatr Gastroenterol Nutr 2016 0.75
43 Donor history of asthma is not a contraindication to lung transplantation: 12-year single-center experience. J Heart Lung Transplant 2004 0.75
44 Aprotinin in lung transplantation is associated with an increased incidence of primary graft dysfunction. Eur J Cardiothorac Surg 2009 0.75
45 Perianal Pediatric Crohn's Disease is Associated With A Distinct Phenotype and Greater Inflammatory Burden. J Pediatr Gastroenterol Nutr 2017 0.75
46 Budesonide use in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2012 0.75